Page last updated: 2024-10-23

bisbenzimidazole and Pituitary Neoplasms

bisbenzimidazole has been researched along with Pituitary Neoplasms in 1 studies

Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.

Pituitary Neoplasms: Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, HS1
Ishizaka, M1
Kazusaka, A1
Fujita, S1

Other Studies

1 other study available for bisbenzimidazole and Pituitary Neoplasms

ArticleYear
Di-(2-ethylhexyl) phthalate suppresses tamoxifen-induced apoptosis in GH3 pituitary cells.
    Archives of toxicology, 2007, Volume: 81, Issue:1

    Topics: Animals; Antineoplastic Agents, Hormonal; Apoptosis; Bisbenzimidazole; Blotting, Western; Cell Line,

2007